We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZTAQW
1426
CALL
DELISTED
Zimmer Energy Transition Acquisition Corp. Warrants
ZTAQW
$2.03M ﹤0.01%
200,572
EGBN icon
1427
Eagle Bancorp
EGBN
$866M
$2.03M ﹤0.01%
+60,696
New +$2.59M
RXO icon
1428
RXO
RXO
$3.73B
$2.03M ﹤0.01%
103,394
-47,604
-32% -$914K
LGND icon
1429
Ligand Pharmaceuticals
LGND
$5.94B
$2.03M ﹤0.01%
27,583
-65,280
-70% -$4.64M
ACRO.WS
1430
CALL
DELISTED
Acropolis Infrastructure Acquisition Corp Warrants
ACRO.WS
$2.03M ﹤0.01%
199,995
AMRC icon
1431
Ameresco
AMRC
$1.04B
$2.02M ﹤0.01%
41,041
+25,959
+172% +$1.38M
BKD icon
1432
Brookdale Senior Living
BKD
$3.67B
$2.01M ﹤0.01%
+682,286
New +$1.96M
PIAI.WS
1433
CALL
DELISTED
Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PIAI.WS
$2.01M ﹤0.01%
192,554
-174,109
-47% -$10K
PNT
1434
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$2M ﹤0.01%
+275,263
New +$2.04M
ECXWW
1435
CALL
ECARX Holdings Warrants
ECXWW
$1.99M ﹤0.01%
340,100
BIOSW
1436
CALL
DELISTED
BioPlus Acquisition Corp. Warrants
BIOSW
$1.99M ﹤0.01%
190,150
LTH icon
1437
Life Time Group Holdings
LTH
$10.2B
$1.98M ﹤0.01%
124,292
-592,502
-83% -$10.2M
ZG icon
1438
Zillow
ZG
$7.74B
$1.98M ﹤0.01%
+45,269
New +$1.88M
ROSS.WS
1439
CALL
DELISTED
Ross Acquisition Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
ROSS.WS
$1.97M ﹤0.01%
192,105
-217,658
-53% -$47.4K
AVAV icon
1440
AeroVironment
AVAV
$7.91B
$1.97M ﹤0.01%
21,459
+17,977
+516% +$1.59M
SP
1441
DELISTED
SP Plus Corporation
SP
$1.96M ﹤0.01%
57,298
-7,900
-12% -$280K
AEAEW
1442
CALL
DELISTED
AltEnergy Acquisition Corp Warrant
AEAEW
$1.96M ﹤0.01%
189,034
SHG icon
1443
Shinhan Financial Group
SHG
$32.8B
$1.96M ﹤0.01%
72,793
-85,962
-54% -$2.62M
SRRK icon
1444
Scholar Rock
SRRK
$5.92B
$1.95M ﹤0.01%
243,525
+39,140
+19% +$397K
VIR icon
1445
Vir Biotechnology
VIR
$1.49B
$1.94M ﹤0.01%
83,561
-114,429
-58% -$2.93M
VRT icon
1446
Vertiv
VRT
$104B
$1.94M ﹤0.01%
135,847
+108,147
+390% +$1.59M
GHIXW
1447
CALL
DELISTED
Gores Holdings IX, Inc. Warrant
GHIXW
$1.94M ﹤0.01%
192,845
CPB icon
1448
Campbell Soup
CPB
$6.8B
$1.94M ﹤0.01%
35,300
-359,503
-91% -$19.1M
TOUR
1449
Tuniu
TOUR
$56.9M
$1.94M ﹤0.01%
103,743
+95,641
+1,180% +$1.92M
ACIW icon
1450
ACI Worldwide
ACIW
$6.1B
$1.94M ﹤0.01%
+71,755
New +$1.9M

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.